ResMed Inc.
US ˙ NYSE ˙ US7611521078

SecurityRMD / ResMed Inc.
InstitutionAxa S.a.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Axa S.a. closes position in RMD / ResMed Inc.

On November 14, 2025 - Axa S.a. filed a 13F-HR form disclosing ownership of 0 shares of ResMed Inc. (US:RMD) valued at $0 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 112,977 shares of ResMed Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F RESMED COM 761152107 0 -100.00 0
2025-08-14 2025-06-30 13F RESMED COM 761152107 112,977 48,997 76.58 29,148 103.53 0.0582
2025-05-15 2025-03-31 13F RESMED COM 761152107 63,980 7,340 12.96 14,322 10.56 0.0470
2025-02-14 2024-12-31 13F RESMED COM 761152107 56,640 4,487 8.60 12,953 1.74 0.0393
2024-11-14 2024-09-30 13F RESMED COM 761152107 52,153 -25,612 -32.94 12,732 -14.47 0.0377
2025-02-25 2024-06-30 13F/A-1 RESMED COM 761152107 77,765 -26,655 -25.53 14,886 -28.02 0.0443
2024-08-14 2024-06-30 13F RESMED COM 761152107 77,765 -26,655 14,886 0.0443
2024-05-15 2024-03-31 13F RESMED COM 761152107 104,420 2,735 2.69 20,678 18.22 0.0620
2024-07-16 2023-12-31 13F/A-1 RESMED COM 761152107 101,685 63,817 168.52 17,492 212.40 0.0564
2024-02-14 2023-12-31 13F RESMED COM 761152107 101,685 63,817 17,492 0.0343
2023-11-14 2023-09-30 13F RESMED COM 761152107 37,868 16,274 75.36 5,600 18.67 0.0197
2023-08-14 2023-06-30 13F RESMED COM 761152107 21,594 75 0.35 4,718 0.13 0.0157
2023-05-15 2023-03-31 13F RESMED COM 761152107 21,519 -49,013 -69.49 4,712 -67.90 0.0162
2023-02-14 2022-12-31 13F RESMED COM 761152107 70,532 -4,153 -5.56 14,680 -9.96 0.0530
2023-02-14 2022-09-30 13F/A-1 ResMed COM 761152107 74,685 7,437 11.06 16,304 15.65 0.0641
2022-11-14 2022-09-30 13F ResMed COM 761152107 74,685 7,437 16,304 0.0641
2023-02-14 2022-06-30 13F/A-1 ResMed COM 761152107 67,248 -12,079 -15.23 14,097 -26.72 0.0522
2022-08-15 2022-06-30 13F ResMed COM 761152107 67,248 -12,079 14,097 0.0522
2023-02-14 2022-03-31 13F/A-1 ResMed COM 761152107 79,327 -1,881 -2.32 19,238 -9.06 0.0547
2022-05-13 2022-03-31 13F ResMed COM 761152107 79,327 -1,881 19,238 0.0547
2022-02-14 2021-12-31 13F ResMed COM 761152107 81,208 -10,241 -11.20 21,153 -12.24 0.0541
2021-11-15 2021-09-30 13F ResMed COM 761152107 91,449 -4,244 -4.44 24,102 2.17 0.0676
2021-08-13 2021-06-30 13F/A-1 ResMed COM 761152107 95,693 20,271 26.88 23,591 61.22 0.0665
2021-08-13 2021-06-30 13F ResMed COM 761152107 95,693 20,271 23,591 0.0398
2021-05-14 2021-03-31 13F ResMed COM 761152107 75,422 -13,178 -14.87 14,633 -22.30 0.0446
2021-02-12 2020-12-31 13F ResMed COM 761152107 88,600 -97 -0.11 18,832 23.85 0.0591
2021-02-11 2020-09-30 13F/A-1 ResMed COM 761152107 88,697 14,204 19.07 15,205 6.31 0.0550
2020-11-13 2020-09-30 13F ResMed COM 761152107 88,697 14,204 15,205 30,351.5932
2021-02-12 2020-06-30 13F/A-1 RESMED COM 761152107 74,493 54,295 268.81 14,303 380.77 0.0564
2020-08-14 2020-06-30 13F RESMED COM 761152107 74,493 54,295 14,303 56,405.9677
2021-02-12 2020-03-31 13F/A-2 RESMED COM 761152107 20,198 17,791 739.14 2,975 697.59 0.0149
2020-06-15 2020-03-31 13F/A-1 RESMED COM 761152107 20,198 0 2,975 0.0149
2020-05-15 2020-03-31 13F RESMED COM 761152107 20,198 17,791 2,975 8,273.5262
2021-02-12 2019-12-31 13F/A-1 RESMED COM 761152107 2,407 248 11.49 373 27.74 0.0015
2020-02-18 2019-12-31 13F RESMED COM 761152107 2,407 248 373 1,518.7285
2021-02-12 2019-09-30 13F/A-1 RESMED COM 761152107 2,159 36 1.70 292 12.74 0.0012
2019-11-14 2019-09-30 13F RESMED COM 761152107 2,159 36 292 1,163.6386
2021-02-12 2019-06-30 13F/A-1 RESMED COM 761152107 2,123 2,123 259 0.0010
2019-08-13 2019-06-30 13F RESMED COM 761152107 2,123 2,123 259 1,015.6891
2019-05-14 2019-03-31 13F RESMED COM 761152107 0 -10,304 -100.00 0 -100.00
2019-02-13 2018-12-31 13F RESMED COM 761152107 10,304 10,304 1,174 0.0051
2017-02-13 2016-12-31 13F RESMED COM 761152107 0 -5,500 -100.00 0 -100.00
2016-11-10 2016-09-30 13F RESMED COM 761152107 5,500 5,500 356 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.